Roles of oral anticoagulant use on the risk of 28-day mortality and in-hospital mortality in patients with acute respiratory distress syndrome
Oral anticoagulant was related to decreased risk of 28-day/in-hospital mortality in patients with ARDS. Warfarin and novel oral anticoagulants showed no significant difference on 28-day/in-hospital mortality in patients with ARDS.
Authors
- Lin Cheng (ORCID: https://orcid.org/0000-0002-6031-3899)
- Wangsheng Li
- Huijie An (ORCID: https://orcid.org/0000-0002-3241-9661)
- Jianping Huang (ORCID: https://orcid.org/0000-0003-1828-0517)
- Dan Su
- Ke‐Shi Zhang (ORCID: https://orcid.org/0000-0002-6260-2029)
Institutions
- Jinan University (CN)
- Southern University of Science and Technology (CN)
- Shenzhen University Health Science Center (CN)
- Shaoxing People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-14
- DOI
- https://doi.org/10.3389/fphar.2025.1565312
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00